BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 15103224)

  • 1. Immunohistochemical detection of estrogen receptor alpha in pituitary adenomas and its correlation with cellular replication.
    Pereira-Lima JF; Marroni CP; Pizarro CB; Barbosa-Coutinho LM; Ferreira NP; Oliveira MC
    Neuroendocrinology; 2004 Mar; 79(3):119-24. PubMed ID: 15103224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunohistochemistry for pituitary hormones and Ki-67 in growth hormone producing pituitary adenomas].
    Brito J; Sáez L; Lemp M; Liberman C; Michelsen H; Araya AV
    Rev Med Chil; 2008 Jul; 136(7):831-6. PubMed ID: 18949157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptors alpha and beta immunohistochemical expression: clinicopathological correlations in pituitary adenomas.
    Manoranjan B; Salehi F; Scheithauer BW; Rotondo F; Kovacs K; Cusimano MD
    Anticancer Res; 2010 Jul; 30(7):2897-904. PubMed ID: 20683030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topoisomerase IIalpha expression in pituitary adenomas and carcinomas: relationship to tumor behavior.
    Vidal S; Kovacs K; Horvath E; Rotondo F; Kuroki T; Lloyd RV; Scheithauer BW
    Mod Pathol; 2002 Nov; 15(11):1205-12. PubMed ID: 12429800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.
    Saeger W; Lüdecke B; Lüdecke DK
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):80-5. PubMed ID: 18072009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinicopathological and immunohistochemical study of clinically non-functioning pituitary adenomas: a single institutional experience.
    Rishi A; Sharma MC; Sarkar C; Jain D; Singh M; Mahapatra AK; Mehta VS; Das TK
    Neurol India; 2010; 58(3):418-23. PubMed ID: 20644271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoplasmic expression of fibroblast growth factor receptor-4 in human pituitary adenomas: relation to tumor type, size, proliferation, and invasiveness.
    Qian ZR; Sano T; Asa SL; Yamada S; Horiguchi H; Tashiro T; Li CC; Hirokawa M; Kovacs K; Ezzat S
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1904-11. PubMed ID: 15070963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary adenoma: a DNA flow cytometric study of 192 clinicopathologically characterized tumors.
    Gaffey TA; Scheithauer BW; Leech RW; Blick K; Kovacs K; Horvath E; Weaver AL; Lloyd RV; Ebersold M; Laws ER; DeBault LE
    Clin Neuropathol; 2005; 24(2):56-63. PubMed ID: 15803804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathology of invasive pituitary tumors with special reference to functional classification.
    Scheithauer BW; Kovacs KT; Laws ER; Randall RV
    J Neurosurg; 1986 Dec; 65(6):733-44. PubMed ID: 3095506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptors in human pituitary tumors.
    Burdman JA; Pauni M; Heredia Sereno GM; Bordón AE
    Horm Metab Res; 2008 Aug; 40(8):524-7. PubMed ID: 18398784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Markers of function and proliferation in non-invasive and invasive bi- and plurihormonal adenomas of patients with acromegaly: an immunohistochemical study.
    Müller W; Saeger W; Wellhausen L; Derwahl KM; Hamacher C; Lüdecke DK
    Pathol Res Pract; 1999; 195(9):595-603. PubMed ID: 10507079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data.
    Buurman H; Saeger W
    Eur J Endocrinol; 2006 May; 154(5):753-8. PubMed ID: 16645024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of RCAS1 in human pituitary adenomas.
    Umeoka K; Sanno N; Oyama K; Tahara S; Kurotani R; Ikuyama S; Nakashima M; Watanabe T; Osamura RY; Teramoto A
    Mod Pathol; 2001 Dec; 14(12):1232-6. PubMed ID: 11743045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical pituitary adenomas: incidence, clinical characteristics, and implications.
    Zada G; Woodmansee WW; Ramkissoon S; Amadio J; Nose V; Laws ER
    J Neurosurg; 2011 Feb; 114(2):336-44. PubMed ID: 20868211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.
    Teramoto A; Sanno N; Tahara S; Osamura YR
    Acta Neuropathol; 2004 Aug; 108(2):147-53. PubMed ID: 15185102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor expression in human pituitary: correlation with immunohistochemistry in normal tissue, and immunohistochemistry and morphology in macroadenomas.
    Friend KE; Chiou YK; Lopes MB; Laws ER; Hughes KM; Shupnik MA
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1497-504. PubMed ID: 7515390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of tumor angiogenic factors in human pituitary adenomas.
    Niveiro M; Aranda FI; Peiró G; Alenda C; Picó A
    Hum Pathol; 2005 Oct; 36(10):1090-5. PubMed ID: 16226108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cell proliferation markers in pituitary adenomas--correlation and clinical relevance of MIB-1 and anti-topoisomerase-IIalpha.
    Wolfsberger S; Wunderer J; Zachenhofer I; Czech T; Böcher-Schwarz HG; Hainfellner J; Knosp E
    Acta Neurochir (Wien); 2004 Aug; 146(8):831-9. PubMed ID: 15254805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-subunit immunoreactivity in plurihormonal pituitary adenomas of patients with acromegaly.
    Kontogeorgos G; Kovacs K; Scheithauer BW; Rologis D; Orphanidis G
    Mod Pathol; 1991 Mar; 4(2):191-5. PubMed ID: 1646455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunohistochemical and clinicoendocrinological studies of gonadotropin producing pituitary adenomas].
    Sanno N; Teramoto A; Inada K; Osamura Y
    No To Shinkei; 1992 Aug; 44(8):745-53. PubMed ID: 1419353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.